Cap-dependent Endonuclease Inhibitor S-033188 for the Treatment of Influenza: Results from a Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study in Otherwise He...

av Portsmouth, Simon, Kawaguchi, Keiko, Arai, Masatsugu, Tsuchiya, Kenji, Uehara, Takeki
I publikationen Open Forum Infect Dis (2017)

1645. Exploring Clinical and Antiviral Efficacy of Baloxavir Marboxil in a Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study of Otherwise Healthy Adults/Adole...

av Kawaguchi, Keiko, Portsmouth, Simon, Shishido, Takao, Uehara, Takeki, Hayden, Frederick
I publikationen Open Forum Infect Dis (2018)

Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 Trial

av Portsmouth, Simon, Hayden, Frederick G, Kawaguchi, Keiko, Ishibashi, Toru, Kinoshita, Masahiro, Shishido, Takao, Tsuchiya, Kenji, Uehara, Takeki
I publikationen J Pediatric Infect Dis Soc (2020)

Carryover effects of baloxavir acid in human nasopharyngeal/pharyngeal swabs on infectious titer testing of influenza virus

av Baba, Keiko, Oka, Ryoko, Shano, Shinya, Omoto, Shinya, Noshi, Takeshi, Shishido, Takao, Naito, Akira, Kawaguchi, Keiko, Ishibashi, Toru, Uehara, Takeki
I publikationen Influenza Other Respir Viruses (2020)

Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil

av Omoto, Shinya, Speranzini, Valentina, Hashimoto, Takashi, Noshi, Takeshi, Yamaguchi, Hiroto, Kawai, Makoto, Kawaguchi, Keiko, Uehara, Takeki, Shishido, Takao, Naito, Akira, Cusack, Stephen
I publikationen Sci Rep (2018)